Resolvins derived from EPA may have specific benefits, as well. “Resolvins appear to signal the end of inflammatory processes, acting like a traffic cop with a stop sign,” says Nettleton. “All of these things are connected. It sometimes seems hard to believe that a group of compounds and their derivatives have so many effects in the body.” The ALA conundrum But what about omega-3 in plant foods (ALA)? “It’s not that the plant sources are bad for you, but they are not providing the same level of long-chain omega-3 fatty acids provided by eating fish. The body needs DHA, and almost no ALA is converted into DHA. There may be some conversion, but it occurs at very low levels, below 1%,” says Nettleton. The pathways for conversion of ALA to long-chain fatty acids compete for the same enzymes as the omega-6 fatty acid, linoleic acid (LA). Unlike long-chain omega-3s, LA is plentiful in the Western diet. That’s not to say that including more omega-3s from plant sources is a bad idea. Many studies have suggested that higher dietary intakes of ALA are linked with significant lowering of coronary heart disease risk. Omega-3s in plants like soy, flax and canola will give some heart-health and immune-function benefits, but due to the low conversion rates they aren’t “as potent as those from the long-chain omega-3 fatty acids,” says Nettleton. “The conversion of ALA to EPA and DHA is still not well understood. But if people increase the amount of ALA without increasing LA, they should experience a higher amount of total conversion to EPA and DHA,” reports Nam Fong Han, Ph.D., president/CEO of Natunola Health Inc., a manufacturer of flaxseed ingredients in based in Ottawa, Ontario. The omega-3 fix Long-chain omega-3s are primarily found in seafood, including salmon, tuna, sardines, mackerel and shellfish. Omega-3-enriched eggs, as well as supplements made of fish-oil, algal or fungal sources, are also good sources of DHA. Supplemental forms of long-chain omega-3 fatty acids usually have lower levels of methylmercury, PCBs and dioxins compared to eating fish. The Institute of Medicine’s Dietary Reference Intake bases recommendations for adequate intake (AI) of omega-3 fatty acids on ALA intake, recognizing that dietary DHA and EPA can meet some of this amount. The AI for ALA is 1.1 to 1.6 grams per day for women and men, respectively. The average adult intake of EPA and DHA is 0.04 to 0.07 grams per day and 0.05 to 0.09 grams per day, respectively. Doses of EPA and DHA used in major studies were 2.0 to 3.0 grams per day of EPA, and about 1.0 to 2.5 grams per day of DHA. Some evidence links the imbalance of omega-6 fatty acid intake vs. omega-3 fatty acid intake as a possible root for the development of chronic diseases such as heart disease, cancer, asthma, arthritis and depression. Optimally, people should consume somewhere between a ratio of 1:1 to 4:1 omega-6 to omega-3 fatty acids, but today, Americans consume about 11 to 30 times more omega-6 than omega 3-fatty acids. “We exhibit high rates of chronic diseases associated with low consumption of omega-3s, such as cardiovascular and immune-related conditions. The United States has one of the lowest intakes of long-chain omega-3 fatty acids in the world,” stresses Nettleton. It’s clear that there will be much attention on the long-chain forms of omega-3 fatty acids in the future. Sharon Palmer is a registered dietitian with 16 years of experience in health-care and foodservice management. She writes on food and nutrition for newspapers, magazines, websites and books. Palmer makes her home in Southern California and can be reached at info@sharonpalmer.com. Shooting Stars Omega-3s have risen to functional superstar status. The market for omega-3-fortified foods, from beverages and cereals to spreads and bakery products, has expanded from $100 million in 2002 to $2 billion in 2006, according to “Omega 3 Fatty Acids and the U.S. Food and Beverage Market,” a new study from Packaged Facts, Rockville, MD. Drinking Up Omega-3 Juice Opportunities According to Zenith International Ltd., Bath, England, global sales of omega-3 beverages were estimated at €5.8 billion in 2006, and it projects a 34% increase through 2011 as these beverages continue to go mainstream. The company’s “Omega-3 Drinks Report 2008” also identifies opportunities in this market: ■ The overall market is supported by a strong juice tradition, especially enriched juice, in the United States; ■ Additionally, omega-3 has increasing penetration of a solid dairy market in Asia and Australasia; ■ The abundance of scientific research showing omega-3 is an essential health component with benefits at every life stage signals increased expansion; ■ The main markets for omega-3 beverage fortification are the more established markets of North America and Western Europe, where the concept has been around for five to ten years; ■ North America and Western Europe experienced the highest growth in 2006, and the strong growth should continue through to 2011.
|